Collapsing focal segmental glomerulosclerosis successfully treated with combination of steroid pulse and low-density lipoprotein apheresis: lessons for the clinical nephrologist

J Nephrol. 2022 May;35(4):1279-1282. doi: 10.1007/s40620-021-01213-9. Epub 2021 Nov 30.

Authors

Yoshitaka Furuto¹, Hirotsugu Hashimoto², Mariko Kawamura³, Hajime Horiuchi², Yuko Shibuya³

Affiliations

¹ Department of Hypertension and Nephrology, NTT Medical Centre Tokyo, 5-9-22, Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan. furuto19761006@yahoo.co.jp.
² Department of Diagnostic Pathology, NTT Medical Centre Tokyo, 5-9-22, Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan.
³ Department of Hypertension and Nephrology, NTT Medical Centre Tokyo, 5-9-22, Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan.

PMID: 34846714
DOI: 10.1007/s40620-021-01213-9

No abstract available

Keywords: Acute kidney injury; Focal segmental glomerulosclerosis collapsing variant; Low-density lipoprotein apheresis; Nephrotic syndrome.

MeSH terms

Blood Component Removal*
Female
Glomerulosclerosis, Focal Segmental* / drug therapy
Humans
Lipoproteins, LDL
Male
Nephrologists
Nephrotic Syndrome* / therapy
Steroids

Substances

Lipoproteins, LDL
Steroids